Activist & passive stakes

Investors crossing the 5% ownership line, from SEC Schedule 13D (activist) and 13G (passive) filings. Newest first.

Showing the last 10 days.Sign up free for 90 days

Filing

New Amendments All

Stake type

Activist Passive

Min % owned

≥10%≥20%

Clear all

All filings, new and amended.1–15 of 15

PassiveAmendment 9
Nov 12, 2026
THO · Thor Inds Inc
Kayne Anderson Rudnick Investment Management, LLC
5.2% · 2,690,130 shSEC
PassiveAmendment 3
Nov 12, 2026
PTHS · Pelthos Therapeutics Inc.
3i, LP
9.9% · 383,447 shSEC
PassiveNew
Nov 12, 2026
THO · Thor Industries Inc
Life Cycle Investment Partners Ltd
8.1% · 4,191,077 shSEC
PassiveNew
Nov 12, 2026
GIX · GigCapital9 Corp.
Lighthouse Investment Partners, LLC
5.66% · 1,454,269 shSEC
PassiveAmendment 1Below 5%
Nov 12, 2026
AUTL · Autolus Therapeutics PLC
Qatar Investment Authority
3.5% · 9,184,404 shSEC
PassiveAmendment 5Below 5%
Nov 10, 2026
PHAT · Phathom Pharmaceuticals Inc
Invesco Ltd.
0% · 30,562 shSEC
PassiveAmendment 4
Nov 10, 2026
BCDA · BioCardia, Inc.
Thomas A. Satterfield, Jr.
9.9% · 1,539,134 shSEC
PassiveAmendment 4
Nov 10, 2026
CRIS · Curis, Inc.
Thomas A. Satterfield, Jr.
8.8% · 616,565 shSEC
PassiveAmendment 1Below 5%
Nov 10, 2026
NVNO · enVVeno Medical Corporation
Thomas A. Satterfield, Jr.
4.8% · 33,470 shSEC
PassiveAmendment 3
Nov 10, 2026
OSTX · OS Therapies Incorporated
Thomas A. Satterfield, Jr.
9.9% · 5,434,150 shSEC
PassiveNew
Nov 9, 2026
IAM · Iambic Therapeutics, Inc.
Qatar Investment Authority
5.8% · 2,804,360 shSEC
PassiveAmendment 2Below 5%
Nov 6, 2026
LIFE · Ethos Technologies Inc.
Gv 2021, L.P.
1.8% · 571,907 shSEC
PassiveNew
Nov 6, 2026
BBTX · Bambusa Therapeutics, Inc.
Thomas Maier
9.2% · 4,699,188 shSEC
PassiveNew
Nov 5, 2026
EQS · Equus Total Return, Inc.
Anthony Prestigiacomo
12.53% · 2,000,000 shSEC
PassiveNew
Nov 3, 2026
ASPE · Aspen Neuroscience, Inc.
Qatar Investment Authority
6.7% · 1,933,330 shSEC

Filing	Symbol	Holder	% Owned	Shares	Filed	SEC filing
PassiveAmendment 9	THO	Kayne Anderson Rudnick Investment Management, LLC in Thor Inds Inc	5.2%	2,690,130	Nov 12, 2026	SEC
PassiveAmendment 3	PTHS	3i, LP in Pelthos Therapeutics Inc.	9.9%	383,447	Nov 12, 2026	SEC
PassiveNew	THO	Life Cycle Investment Partners Ltd in Thor Industries Inc	8.1%	4,191,077	Nov 12, 2026	SEC
PassiveNew	GIX	Lighthouse Investment Partners, LLC in GigCapital9 Corp.	5.66%	1,454,269	Nov 12, 2026	SEC
PassiveAmendment 1Below 5%	AUTL	Qatar Investment Authority in Autolus Therapeutics PLC	3.5%	9,184,404	Nov 12, 2026	SEC
PassiveAmendment 5Below 5%	PHAT	Invesco Ltd. in Phathom Pharmaceuticals Inc	0%	30,562	Nov 10, 2026	SEC
PassiveAmendment 4	BCDA	Thomas A. Satterfield, Jr. in BioCardia, Inc.	9.9%	1,539,134	Nov 10, 2026	SEC
PassiveAmendment 4	CRIS	Thomas A. Satterfield, Jr. in Curis, Inc.	8.8%	616,565	Nov 10, 2026	SEC
PassiveAmendment 1Below 5%	NVNO	Thomas A. Satterfield, Jr. in enVVeno Medical Corporation	4.8%	33,470	Nov 10, 2026	SEC
PassiveAmendment 3	OSTX	Thomas A. Satterfield, Jr. in OS Therapies Incorporated	9.9%	5,434,150	Nov 10, 2026	SEC
PassiveNew	IAM	Qatar Investment Authority in Iambic Therapeutics, Inc.	5.8%	2,804,360	Nov 9, 2026	SEC
PassiveAmendment 2Below 5%	LIFE	Gv 2021, L.P. in Ethos Technologies Inc.	1.8%	571,907	Nov 6, 2026	SEC
PassiveNew	BBTX	Thomas Maier in Bambusa Therapeutics, Inc.	9.2%	4,699,188	Nov 6, 2026	SEC
PassiveNew	EQS	Anthony Prestigiacomo in Equus Total Return, Inc.	12.53%	2,000,000	Nov 5, 2026	SEC
PassiveNew	ASPE	Qatar Investment Authority in Aspen Neuroscience, Inc.	6.7%	1,933,330	Nov 3, 2026	SEC